ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: SA-PO110

Protein O-GlcNAcylation Regulates Renal Lipolysis During Fasting and Diabetes

Session Information

Category: Diabetic Kidney Disease

  • 601 Diabetic Kidney Disease: Basic

Authors

  • Sugahara, Sho, Shiga University of Medical Science, Otsu, SHIGA, Japan
  • Kume, Shinji, Shiga University of Medical Science, Otsu, SHIGA, Japan
  • Yamahara, Kosuke, Shiga University of Medical Science, Otsu, SHIGA, Japan
  • Yamahara, Mako, Shiga University of Medical Science, Otsu, SHIGA, Japan
  • Takeda, Naoko, Shiga University of Medical Science, Otsu, SHIGA, Japan
  • Osawa, Norihisa, Shiga University of Medical Science, Otsu, SHIGA, Japan
  • Kanasaki, Masami, Shiga University of Medical Science, Otsu, SHIGA, Japan
  • Yanagita, Motoko, Department of Nephrology, Kyoto University Graduate School of Medicine, Kyoto, Japan
  • Araki, Shin-ichi, Shiga University of Medical Science, Otsu, SHIGA, Japan
  • Maegawa, Hiroshi, Shiga University of Medical Science, Otsu, SHIGA, Japan
Background

Energy metabolism in kidney proximal tubular cells (PTCs) is unique because their ATP production largely depends on lipolysis rather than glycolysis, regardless of feeding or fasting. Furthermore, disrupted renal lipolysis is involved in the pathogenesis of tubular damage in various kidney diseases including diabetic kidney disease. Thus, elucidating detailed mechanisms of renal fatty acid metabolism should contribute to a novel therapy for kidney diseases. O-GlcNAcylation is a post-translational modification and acts an intracellular nutrient sensor. This study was designed to examine the role of O-GlcNAcylation in renal fatty acid metabolism under fasting and diabetes.

Methods

O-GlcNAc transferase (Ogt) is the sole enzyme for O-GlcNAcylation.We generated inducible PTC-specific Ogt-knockout mice (PTC-Ogty/-mice) by crossbreeding female Ogtf/fmice with male tamoxifen-inducible PTC-specific Cre transgenic mice (NDRG1-CreERT2mice), and analyzed their renal phenotype under fasting and high fat diet (HFD)-induced obese diabetes.

Results

PTC-Ogty/-mice showed no significant renal phenotype under ad-libitum feeding condition, but showed significant increases in urinary excretions of albumin, glucose and various ions after 48 hours fasting. Cellular apoptosis, significant intracellular lipid droplet accumulation, mitochondrial fragmentation and decreased ATP contents in renal cortex were observed in PTCs of fasted PTC-Ogty/-mice. Furthermore, PTC-Ogty/-mice developed severe tubular cell damage under HFD-induced obesity diabetic condition. Proteomic analysis revealed that PTC-Ogty/-mice showed significant change in lipid metabolism pathway and dramatic decrease in protein expression level of a neutral lipid esterase, Carboxilesterase-1 (CES-1), which was associated with decreased activity in Farnesoid X receptor (FXR).

Conclusion

Protein O-GlcNAcylation is essential for maintaining renal lipolysis under fasting and obesity diabetic condition through regulating FXR-CES1 axis.